Subcutaneous Versus Sublingual Immunotherapy for Allergic Rhinitis and/or Asthma

Nerin Nadir Bahceciler; Nazan Cobanoglu


Immunotherapy. 2011;3(6):747-756. 

In This Article

Effector Cells

Moreover, SCIT has been shown to decrease the numbers of effector cells at mucosal sites, both during seasonal allergen exposure and after allergen challenge,[91,94] as well as reducing effector cell reactivity in vitro.[83]


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.